DSOL OTC
Drug Free Solution, Inc.
1W: +0.0%
1M: +0.0%
3M: +100.0%
YTD: -63.6%
1Y: -63.6%
3Y: +300.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$53K
+190.9% ▲
Total Liabilities
$333K
+30.0% ▲
Shareholders Equity
-$281K
-17.9% ▼
Cash & Investments
$13K
+394.9% ▲
Total Debt
$0
+0.0% ▲
Net Debt
-$13K
-394.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2012 | FY2018 | FY2019 |
|---|---|---|---|
| — Assets — | |||
| Cash | $8K | $3K | $13K |
| Short-Term Investments | $0 | $0 | $0 |
| Cash & ST Investments | $8K | $3K | $13K |
| Net Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 |
| Total Current Assets | $8K | $3K | $13K |
| Property, Plant & Equip. | $4K | $0 | $0 |
| Goodwill & Intangibles | $0 | $16K | $40K |
| Long-Term Investments | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 |
| Total Non-Current Assets | $4K | $16K | $40K |
| Total Assets | $12K | $18K | $53K |
| — Liabilities — | |||
| Accounts Payable | $21K | $0 | $15K |
| Short-Term Debt | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $256K | $318K |
| Total Current Liabilities | $63K | $256K | $333K |
| Long-Term Debt | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 | $0 |
| Total Liabilities | $63K | $256K | $333K |
| — Equity — | |||
| Common Stock | $29K | $199K | $428K |
| Retained Earnings | -$1M | -$4M | -$5M |
| Accumulated OCI | -$0 | $4M | $5M |
| Total Stockholders Equity | -$51K | -$238K | -$281K |
| Total Liabilities & Equity | $12K | $18K | $53K |
| — Key Metrics — | |||
| Total Debt | $0 | $0 | $0 |
| Net Debt | -$8K | -$3K | -$13K |
| Total Investments | $0 | $0 | $0 |